FDA Expected To Give Pfizer COVID Vaccine Full Approval Monday

(Washington, DC) — The FDA is likely to give the Pfizer-BioNTech COVID vaccine full approval as early as Monday. That’s according to a report from the New York Times. If it happens, it would be the first coronavirus vaccine to receive full approval from the FDA. CDC data from Friday shows over 200-million Pfizer vaccine doses have been administered in the U.S., fully immunizing more than 91 million Americans.

More about: